Delivery Order SPE2DB22D3501-SPE2DB25FWK67
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 20, 2025, for Venofer (iron sucrose) 100 mg/5 ml vials with a ceiling value of $2,454.96 and an ultimate completion date of June 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on merit. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $8,440.81 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials. This competitively awarded, firm fixed-price contract was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,222.42 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,533 to AmerisourceBergen Drug Corp for Venofer 100 mg/5 mL vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order represents a direct purchase of the iron sucrose injection medication, which is commonly used to treat iron deficiency anemia in patients undergoing dialysis. The contract was placed to AmerisourceBergen's Corporate Office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,154.32 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,121.06, is for the delivery of Venofer 200 mg/10 ml vials to support military healthcare programs. The contract has a firm fixed price pricing type and a completion date of November 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, to supply Venofer 100 mg/5 ml vials to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,166.13, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025 for a comprehensive range of medical commodities. The contract is for...
- This is a delivery order awarded to Amerisourcebergen Drug Corp (a subsidiary of Amerisourcebergen Corporation) by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for Venofer 100 mg/5 ml vials, with a firm fixed price ceiling of $1,430.72 and an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor for this order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00...
- This contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Venofer 100 mg/5 ml vials, a pharmaceutical product used in the treatment of iron deficiency anemia. The $3,119.19 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency that provides medical supplies and equipment to military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Venofer 100 mg/5 ml vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award has a ceiling value of $3,553.46 and an ultimate completion date of December 22, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside....
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWK67Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Venofer 100 mg/5 mL vials with a ceiling value of $1,502.16 and firm fixed pricing. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made without set-aside designation through competitive procurement, reflecting AmerisourceBergen's established capability to meet federal medical supply requirements. Performance will be executed from the company's Conshohocken, Pennsylvania location. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. Venofer (iron sucrose) is an intravenous iron replacement therapy commonly used in military medical facilities and veteran healthcare systems to treat iron deficiency anemia, particularly in patients with chronic kidney disease. This delivery order exemplifies the company's role in supporting the Defense Health Agency and broader military healthcare operations through flexible contract vehicles that enable efficient procurement and distribution of specialized pharmaceutical commodities to support military readiness and personnel health worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/15/25 |